Skip to content

Post Market Clinical Follow Up Investigation of Skanmobile and Skanmobile DR

A prospective, post market, non-interventional observational, open label, single arm, single center study to validate the clinical safety and performance of Skanmobile and Skanmobile DR

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/028059
Enrollment
15
Registered
2020-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M955- Acquired deformity of pelvis Health Condition 2: N219- Calculus of lower urinary tract, unspecified Health Condition 3: M259- Joint disorder, unspecified Health Condition 4: J709- Respiratory conditions due to unspecified external agent

Interventions

Intervention1: Radiographic examination: Acquisition of radiographic image as per the standard radiological procedure. Intervention2: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Skanray Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and non pregnant female subjects of all age groups. Subjects or legally authorised representatives or guardians on behalf of the subject who are able and willing to provide written informed consent to participate in this clinical investigation.

Exclusion criteria

Exclusion criteria: Pregnant or suspected to be pregnant based on the opinion of a physician.

Design outcomes

Primary

MeasureTime frame
Collection of feedback which includes investigator�s assessment of the overall safety and performance of the Skanmobile and Skanmobile DR found to be appropriate to meet the predefined objectives.Timepoint: Within 14 days after capturing the radiographic image

Secondary

MeasureTime frame
Collection of feedback from the investigator on the radiographic images collected during the study and usability. This shall meet the predefined objectives to prove the claimed performance of Skanmobile and Skanmobile DR.Timepoint: Within 20 days after capturing the radiographic image.

Countries

India

Contacts

Public ContactVasundhara R

Department of Radio-diagnosis and Imaging JSS Hospital

Vikrampatil@jssuni.edu.in9886896511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026